FDA greenlights Teligent’s topical steroid: 3 things to know

The FDA approved Teligent’s betamethasone dipropionate lotion Wednesday.

Advertisement

Here are three things to know.

1. Betamethasone dipropionate is a topical steroid used to treat itching and other skin conditions, like eczema.

2. The regulatory decision represents Teligent’s first approval of 2018 and the 20th from its pipeline of topical generic drugs.

3. The lotion will launch in the first quarter of 2018.

More articles on supply chain:
Pfizer’s opioid-filled syringes hit another manufacturing snag: 6 things to know
Amazon pushes to become a major hospital supplier: 7 things to know
Walgreens is reportedly in talks to purchase AmerisourceBergen: 7 things to know

Advertisement

Next Up in Supply Chain

  • Medline is laying off 304 workers, according to a notice filed with the state of Illinois and a Nov. 5…

  • As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

Advertisement

Comments are closed.